The weight loss piece is honestly where it gets interesting though
If youre looking into GLP-1 medications for weight loss, youve probably come across two big names: semaglutide and tirzepatide
For example, in STEP 1 in the placebo group, the sample reported for the week 68 percentage change from baseline in weight was 577 patients, which is 12% less than the original baseline sample of 655, despite the fact that 7% of patients were reported as having withdrawn from the study in this group, and 22% were reported as having stopped treatment
Finally, staying informed about the latest research on semaglutide and supplement interactions can empower you to make educated decisions about your health regimen
Semaglutide is contraindicated for people with: A personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Type 1 diabetes or diabetic ketoacidosis Known allergy to semaglutide or its ingredients Currently pregnant or breastfeeding Discuss with your doctor if you have: History of pancreatitis History of gallbladder disease Severe gastrointestinal problems or gastroparesis Diabetic retinopathy Severe kidney disease History of suicidal thoughts (for weight loss use) Age restrictions: Semaglutide is not approved for people under the age of 18
This analysis assumes that the missing data mechanism is missing at random